As the third-quarter earnings season gains momentum, investors are watching for companies that consistently outperform Wall Street forecasts and deliver post-report stock gains. Historical data shows ... ...

The US consumer price index (CPI) rose 0.3% in September from the previous month, bringing the annual inflation rate to 3%, the Labor Department said on Friday. The reading came in marginally below economists' expectations of a 0.4% monthly gain and a 3.1% annual increase, according to a Dow Jones survey. ...

Industry Overview - Quantum computing stocks have seen significant price increases, with some companies doubling or tripling in value due to speculative momentum and investor enthusiasm [1][2] - The excitement is driven by the potential of quantum technology to transform sectors like drug discovery, cryptography, and artificial intelligence, despite most companies being pre-revenue [1] Rigetti Computing - Rigetti Computing has experienced a remarkable stock surge, up approximately 183% year-to-date and over 4,500% in the past 12 months, despite a recent 25% pullback from its 52-week high [4][5] - In Q2 2025, Rigetti reported revenues of $1.8 million, a decline of 41.9% year-over-year, with net losses of $39.7 million and an EPS of -5 cents [5] - The company's current valuation is nearly $14 billion, trading at over 1,700 times sales, indicating a highly speculative investment [6] BTQ Technologies - BTQ Technologies has rapidly gained attention since its Nasdaq debut in late September 2025, focusing on post-quantum cryptography [8][9] - The stock has surged 281% year-to-date and 122% in the past month, driven by retail speculation and interest in quantum-proof cybersecurity [9][10] - For Q2, BTQ reported sales of approximately $47,000, down from $65,000 a year ago, with a net loss of roughly $1.4 million [10] Churchill Capital Corp X - Churchill Capital Corp X is positioned as a credible entry point into quantum computing following its merger announcement with Infleqtion, valued at $1.8 billion [11][12] - Infleqtion generated nearly $29 million in trailing 12-month revenue, growing at an impressive 80% CAGR, providing a tangible revenue base for the future merged entity [14] - Citron Research has rated Infleqtion as "far superior to Rigetti," with a fair value estimate of $55 per share, indicating a favorable risk-reward profile for investors [15]

Core Points - Park Ha Biological Technology Co., Ltd. will change its ticker symbol from "PHH" to "BYAH" effective October 28, 2025 [1][2] - The change is intended to prevent confusion with a delisted company that previously used the same symbol and aims to enhance the Company's long-term brand influence and value [2] Company Overview - Established in 2016, Park Ha Biological Technology Co., Ltd. focuses on developing its private skincare label and promoting direct skincare product sales and franchise alliances under the brand "Park Ha" [4] - As of April 30, 2025, the Company operates three directly operated stores and has 39 franchisees in China, with 38 operating under "Park Ha" and one under "Geni" [4] - The Company offers a "light beauty experience," a complimentary after-sales beauty service in its stores, to add value to its products [4]

Core Insights - Mr. Mavroudis is a professional portfolio manager with a focus on risk management and in-depth financial market analysis [1] - He has successfully navigated major crises, including the COVID-19 pandemic and the PSI [1] - Mr. Mavroudis is the CEO of FAST FINANCE Investment Services, a registered Greek company [1] Professional Background - Holds an MSc in Financial and Banking Management, an LLM in Law, and a BSc in Economics, graduating as valedictorian [1] - Certified portfolio manager and analyst for financial instruments, with additional certifications in derivatives and securities market-making [1] - Licensed Class A accountant-tax consultant and member of the Economic Chamber of Greece [1] Contributions and Engagement - Writes daily articles for reputable financial media and appears as a guest commentator on television and online programs [1] - Published three books on investments and teaches in educational seminars [1] - Engages with the investment community through Seeking Alpha to foster mutual growth and knowledge sharing [1]

Core Viewpoint - Southern Company is expected to report third-quarter earnings of $1.50 per share on revenues of $7.6 billion, reflecting a year-over-year improvement in earnings and revenue despite potential cost pressures [1][8]. Group 1: Previous Quarter Performance - In the last reported quarter, Southern Company achieved adjusted earnings per share of 91 cents, exceeding the Zacks Consensus Estimate by 4 cents, with sales of $7 billion surpassing the consensus by 6.2% [2]. - The company has topped the Zacks Consensus Estimate for earnings in three of the last four quarters, with an average earnings surprise of 3.2% [3]. Group 2: Third Quarter Estimates - The Zacks Consensus Estimate for the third-quarter earnings has been revised 2% downward in the past week, indicating a 4.9% improvement year over year, while revenue estimates suggest a 4.1% increase from the previous year [3]. - The estimated net income for Southern Company is projected at $1.5 billion, reflecting a 0.9% decrease from the year-ago quarter [5]. Group 3: Market and Economic Factors - Southern Company serves 9 million customers in the Southeast, benefiting from strong regional economic growth and significant capital investments, with $2 billion in new projects and 6,000 jobs announced in the second quarter of 2025 [4]. - Demand from industrial and data center sectors is expected to continue driving long-term load expansion, positively impacting earnings and cash flows [4]. Group 4: Cost Pressures - The company has flagged risks related to timing and costs associated with new capacity delivery, with upward pressure on generation costs and higher operating expenses noted in the previous quarter [5]. - The increasing cost trend is anticipated to persist in the third quarter, potentially affecting overall earnings negatively [5]. Group 5: Earnings Prediction Model - The Zacks model does not predict a definitive earnings beat for Southern Company in the third quarter, with an Earnings ESP of -0.22% and a Zacks Rank of 3 [6][7].

Core Points - Interactive Strength Inc. will release its financial results for the third quarter ended September 30, 2025, on November 14, 2025 [1] - The company is known for its innovative specialty fitness equipment under the CLMBR, FORME, and Wattbike brands [1] - The company is also a pending acquirer of Sportstech [1] Financial Results Announcement - The financial results will be published as the market opens on the specified date [1] - Following the filing of its Form 10-Q, the company will issue a shareholder letter discussing the results and business outlook [1]

Core Insights - Lumen Technologies stock surged 11% following a strategic alliance with Palantir Technologies valued at over $200 million, marking a significant shift towards becoming a technology infrastructure firm [2][10] - The partnership integrates Palantir's AI capabilities with Lumen's network infrastructure, aiming to deliver advanced enterprise AI solutions [3][4] - Lumen's CEO highlighted the collaboration as a solution for secure and efficient data transfer across multi-cloud environments, addressing a critical market need [4] Financial Performance - Lumen's financial metrics indicate significant undervaluation, with a price-to-sales ratio of 0.6x compared to 3.2x for the S&P 500, and a price-to-free cash flow ratio of 8.4x versus 21.1x for the S&P 500 [7][6] - The company has faced a three-year average revenue decline of 12.2%, with the most recent 12-month revenues decreasing from $14 billion to $13 billion, and quarterly revenues dropping 5.4% year-over-year to $3.1 billion [13] - Total debt stands at $18 billion against a market capitalization of $7.7 billion, resulting in a debt-to-equity ratio of 230.7% compared to 21.1% for the S&P 500 [14] Strategic Outlook - The partnership with Palantir is expected to provide revenue visibility through the $200 million commitment and supports Lumen's goal of achieving $1 billion in cost reductions by 2027, positioning the company for potential margin growth [10] - Despite the positive developments, Lumen's stock may be overvalued at $8, with analyst price targets averaging around $5, reflecting concerns over the company's debt load and declining revenues [11][12]

BREAKING: Core CPI Inflation Unexpectedly DipsGSK (GSK) stock crumbled Friday after the Food and Drug Administration granted its blood cancer treatment, Blenrep, a narrower-than-expected approval.The agency signed off on several combinations using Blenrep to treat multiple myeloma patients who've undergone at least three prior lines of therapy.GSK was gunning for a comeback with Blenrep. Blenrep won accelerated approval in 2020. But the drug failed its confirmatory study and GSK pulled it from the market in ...

Union Pacific Corporation (NYSE:UNP) reported better-than-expected earnings for the third quarter on Thursday, driven by operational efficiency gains and core pricing.The rail transportation company announced net income of $1.8 billion, or $3.01 per diluted share. Including the effect of merger costs of $41 million, adjusted diluted EPS was $3.08, which beat the analyst estimate of $2.99.The company's operating revenue increased 3% to $6.244 billion, which narrowly missed the analyst estimate of $6.245 bill ...